Paxlovid may not significantly benefit vaccinated seniors

We’ve all become more adept at managing COVID-19, from recognizing its symptoms to testing ourselves and seeking out antiviral treatments like Paxlovid. But since the initial studies on that drug were done, one major thing has changed: Most people in the U.S. are now vaccinated.

So how effective is Paxlovid in vaccinated people who are also at high risk of severe COVID-19? Here’s what researchers recently learned.

If you were forwarded this and want to sign up to receive it daily, click here. Today's newsletter was written by Alice Park and edited by Angela Haupt.